The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas

References

• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and molecular regulation. Nat Med 1995; 1: 27–31
   PubMed Web of Science ®Google Scholar
• Beck L J, D'Amore P. Vascular development: cellular and molecular regulation. FASEB J 1997; 11: 365–373
   PubMed Web of Science ®Google Scholar
• Ellis I, Filde I. Angiogenesis and metastasis. Eur J Cancer 1996; 32A: 2451–2460
   PubMed Web of Science ®Google Scholar
• Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh I, Cao Y, et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 1997; 16: 3898–3911
   PubMed Web of Science ®Google Scholar
• Franchi A, Gallo O, Baroni G, Santucci M. Tumor lymphangiogenesis in head and neck squamous cell carcinoma. Cancer 2004; 101: 973–978
   PubMed Web of Science ®Google Scholar
• Mohammed R AA, Green A, El-Shikh S, Paish E C, Ellis I O, Martin S G. Prognostic significance of vascular endothelial cell growth factors-A-C- and -D in breast cancer and their relationship with angio- and lymhangiogenesis. Br J Cancer 2007; 96: 1092–1100
   PubMed Web of Science ®Google Scholar
• Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y. Clinical significance of vascular endothelial growth factor C and non-small cell lung carcinoma. Cancer 2003; 97: 457–464
   PubMed Web of Science ®Google Scholar
• Nagy J A, Vasile E, Feng D, Sundberg C, Brown L F, Detmar M J, et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 2002; 196: 1497–1506
   PubMed Web of Science ®Google Scholar
• Jeltsch M, Kaipinen A, Joukov V, Meng X, Lakso M, Rauvala H, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997; 276: 1423–1425
   PubMed Web of Science ®Google Scholar
• Salven P, Orpana A, Teerenhovi L, Joensuu H. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and b FGF is an independent predictor of poor prognosis in non-Hodgkin's lymphoma: a single-institution study of 200 patients. Blood 2000; 96: 3712–3717
   PubMed Web of Science ®Google Scholar
• Salven P, Teerenhovi L, Joensuu H. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 1997; 90: 3167–3172
   PubMed Web of Science ®Google Scholar
• Moehler T M, Ho A D, Golschmidt H, Barlogie B. Angiogenesis in hematologic malignancies. Crit Rev Oncol Hematol 2003; 45: 227–244
   PubMed Web of Science ®Google Scholar
• Rajkumar S V, Leong T, Roche P C, Fonseca R, Dipenzieri A, Lacy M Q, et al. Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 2000; 6: 3111–3116
   PubMed Web of Science ®Google Scholar
• Vacca A, Ribatti D, Ruco L, Giacchetta F, Nico B, Quondamatteo F, et al. Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphoma. Br J Cancer 1999; 79: 965–970
   PubMed Web of Science ®Google Scholar
• Salven P. Angiogenesis in lymphoproliferative disorders. Acta Haematol 2001; 106: 184–189
   PubMed Web of Science ®Google Scholar
• Giles F J, Vose J M, Do K A, Johnson M M, Manshouri T, Bociek G, et al. Clinical relevance o circulating angiogenic factors in patients with non-Hodgkin's lymphoma. Leuk Res 2004; 28: 595–604
   PubMed Web of Science ®Google Scholar
• Hoss H D, Araujo I, Demel G, Klotzbach H, Hummel M, Stein H. Expression of vascular endothelial growth factor in lymphomas and Castleman disease. J Pathol 1997; 183: 44–50
   PubMed Web of Science ®Google Scholar
• Hazar B, Paydas S, Zorludemir S, Sahin B, Tuncer I. Prognostic significance of vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma. Leuk Lymphoma 2003; 44: 2089–2093
   PubMed Web of Science ®Google Scholar
• Hayashibara T, Yamada Y, Onimura Y, Tsutsumi C, Nakayama S, Mori N, et al. Matrix metalloproteinase-9 and vascular endothelial growth factor: a possible link in adult T-cell leukemia cell invasion. Br J Haematol 2002; 116: 94–102
   PubMed Web of Science ®Google Scholar
• Potti A, Ganti A K, Kargas S, Koch M. Immunohistochemical detection of c kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in mantle cell lymphoma. Anticancer 2002; 22: 2899–2901
   PubMed Web of Science ®Google Scholar
• Kini A R, Kay N E, Peterson L C. Increased bone marrow angiogenesis n B-cell chronic lymphocytic leukemia. Leukemia 2000; 14: 1414–1418
   PubMed Web of Science ®Google Scholar
• Vacca A, Ribatti D, Roncali L, Dammacco F. Angiogenesis in B-cell lymphoproliferative diseases. Leuk Lymphoma 1995; 20: 27–38
   PubMed Web of Science ®Google Scholar
• Crivelato E, Nico B, Vacca A, Ribatti A. B-cell non-Hodgkin's lymphomas Express heterogeneous patterns of neovascularization. Haematologica 2003; 88: 671–678
   PubMed Web of Science ®Google Scholar
• Paydas S, Ergin M, Erdogan S, Seydaoglu G. Prognostic significance of EBV-LMP-1 and VEGF-A expressions in non-Hodgkin's lymphomas. Leuk Res 2008; 32: 1424–1430
   PubMed Web of Science ®Google Scholar
• Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V, et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA 1998; 95: 14389–14394
   PubMed Web of Science ®Google Scholar
• Streit M, Detman M. Angiogenesis, lymphangiogenesis and melanoma metastasis. Oncogene 2003; 22: 3172–3179
   PubMed Web of Science ®Google Scholar
• Pepper M S. Lymphangiogenesis and tumor metastasis. Myth or reality?. Clin Cancer Res 2001; 7: 462–468
   PubMed Web of Science ®Google Scholar
• Tsuruski T, Kanda S, Sakai H, Kaneteke H, Saito Y, Alitalo K, et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 1999; 80: 309–313
   PubMed Web of Science ®Google Scholar
• Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E, et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 1999; 5: 1823–1829
   PubMed Web of Science ®Google Scholar
• Akagi K, Ikeda Y, Miyazaki M, Abe T, Kinoshita J, Maehra Y, et al. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 2000; 83: 887–891
   PubMed Web of Science ®Google Scholar
• Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 2000; 6: 2431–2439
   PubMed Web of Science ®Google Scholar
• Schoppman S F, Birner P, Studer P, Breiteneder-Gelefi S. Lymphatic microvessel density and lymphovascular invasion assessed by anti-padoplanin immunostaining in human breast cancer. Anticancer Res 2001; 21: 2351–2355
   PubMed Web of Science ®Google Scholar
• Kinoshita J, Ktamura K, Kabashima A, Saeki H, Tanaka S, Sugimachi K. Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer. Breast Cancer Res Treat 2001; 66: 159–164
   PubMed Web of Science ®Google Scholar
• Tang R F, Itakura J, Aikawa T, Matsuda K, Fujii H, Korc M, et al. Overexpression of lymphangiogenesis growth factor VEGF-C in human pancreatic cancer. Pancreas 2001; 3: 285–292
   Web of Science ®Google Scholar
• Yokoyama Y, Charnock-Jones D S, Licence D, Yanalhara A, Hastingo J M, Holland J M, et al. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian cancer. Br J Cancer 2003; 88: 237–244
   PubMed Web of Science ®Google Scholar
• Hirai M, Nakagawara A, Oosaki T, Hayashi Y, Hirono M, Yoshihara T. Expression of vascular endothelial growth factor (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma. Gynecol Oncol 2001; 80: 181–188
   PubMed Web of Science ®Google Scholar
• Hoar F J, Chaudhri S, Wadley M S, Stonaleke P S. Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erbB2 in human breast carcinoma. Eur J Cancer 2003; 39: 1698–1703
   PubMed Web of Science ®Google Scholar
• Kurebayashi J, Otsuki T, Kuisue H, Mikami Y, Tanaka K, Yamamoto S, et al. Expression of vascular endothelial growth factor family members in breast cancer. Jpn J Cancer Res 1999; 90: 977–981
   PubMedGoogle Scholar
• Suzuki K, Morita T, Tokue A. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder. Int J Urol 2005; 12: 152–158
   PubMed Web of Science ®Google Scholar
• Bunone G, Vigneri P, Mariani L, But S, Collioni P, Pilotti S, et al. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 1999; 155: 1967–1976
   PubMed Web of Science ®Google Scholar
• Nishida N, Yano H, Komai K, Nishida T, Kamura T. Vascular endothelial growth factor C and Vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma. Cancer 2004; 101: 1364–1374
   PubMed Web of Science ®Google Scholar
• Neuchrist C, Erovic B M, Hadisurya A, Fischer M B, Steiner G E, Holemann D, et al. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head Neck 2003; 25: 464–474
   PubMed Web of Science ®Google Scholar
• Choi W W, Lewis M M, Lawson D, Yin-Goen Q, Birdsong G G, Cotsonis G A, et al. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Mod Pathol 2005; 1: 143–152
   Web of Science ®Google Scholar
• Kojima M, Shiokawa A, Ohike N, Ohta Y, Kato H, Iwaku K, et al. Clinical significance of nuclear morphometry at the invasive front of T1 colorectal cancer and relation to expression of VEGF-A and VEGF-C. Oncology 2005; 68: 230–238
   PubMed Web of Science ®Google Scholar
• Salven P, Lymbossaki A, Heikkila P, Sari H S, Enholm B, Aase K, et al. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 1998; 153: 103–108
   PubMed Web of Science ®Google Scholar
• Strauss L, Volland D, Kunkel M, Reichert T E. Dual role of VEGF family members in the pathogenesis of head and neck cancer (HNSCC): possible link between angiogenesis and immune tolerance. Med Sci Monit 2005; 11: 280–292
   Google Scholar
• Muinoz-Guerra M F, Marazuela E G, Martin-Villar E, Quintanilla M, Gamallo C. Prognostic significance of intratumoral lymphangiogenesis in squamous cell carcinoma of the oral cavity. Cancer 2004; 100: 553–560
   PubMed Web of Science ®Google Scholar
• Kudowaki I, Ichinohasama R, Harigae H, Ishizawa K, Okitsu Y, Kameoka J, et al. Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C. Br J Haematol 2005; 130: 869–877
   PubMed Web of Science ®Google Scholar
• Wrobel T, Mazur G, Dzie P, Jelen M, Szuba A, Kulickowski K, et al. Density of intranodal lymphatics and reactive lymph nodes. Folia Histochemica et Cytobiologica 2006; 44: 43–47
   PubMed Web of Science ®Google Scholar
• Ganjoo K N, Moore A M, Orazi A, Sen J A, Johnson C S, An C S. The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients. J Cancer Res Clin Oncol 2008; 134: 381–387
   PubMed Web of Science ®Google Scholar
• Skobe M, Hamberg M L, Hawighorst T, Schirmer M, Wolf G L, Alitalo K, et al. Concurrent induction of lymhangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma. Am J Pathol 2001; 159: 893–903
   PubMed Web of Science ®Google Scholar
• Angeli V, Ginhoux F, Llodra J, Quemenuer L, Frenette P S, Skobe M, et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 2006; 24: 203–215
   PubMed Web of Science ®Google Scholar
• Oh S J, Jeltsch M M, Birkenhager R, McCarthy J E, Weich H A, Christ B, et al. VEGF- and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 1997; 188: 96–109
   PubMed Web of Science ®Google Scholar
• Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown L F, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005; 201: 1089–1099
   PubMed Web of Science ®Google Scholar
• Dudek A Z, Bodempudi V, Welsh B W, Jasinski P, Griffin R J, Milbauer L, et al. Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy. Br J Cancer 2007; 97: 513–522
   PubMed Web of Science ®Google Scholar